Raclopride

DB12518InvestigationalSmall molecule

Raclopride has been used in trials studying Parkinson Disease.

Chemical structure of Raclopride
Mechanism
Curator reviewed
Formula / weight
C15H20Cl2N2O3 · 347.24 g/mol (avg)
Code names
FLA 870

Resolves to

Compound
UNII430K3SOZ7GCAS84225-95-6ChEMBLCHEMBL8809ChEBI92070PubChem3033769
Structure
InChIKeyWAOQONBSWFLFPE-VIFPVBQESA-NSMILESCCN1CCC[C@H]1CNC(=O)C1=C(O)C(Cl)=CC(Cl)=C1OC
Targets
P14416DRD2P06213INSR

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
727Drug interactionsStructured to mechanism, not free text
Sign in
14Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Raclopride, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In